Brincidofovir (trade name Chimerix) is an antiviral drug used for the treatment of certain viral infections. It is a prodrug of the active metabolite cidofovir, which is a nucleotide analog used to inhibit viral replication. Brincidofovir is approved by the US Food and Drug Administration (FDA) for the treatment of cytomegalovirus (CMV) infection and adenovirus infection in immunocompromised adults and children, as well as for the prevention of CMV infection in transplant recipients. It is also being investigated for the treatment of other viral infections, including human papillomavirus (HPV) and herpes simplex virus type 1 (HSV-1).
Brincidofovir, sold under the brand name Revira, is an antiviral medication used to treat cytomegalovirus (CMV) retinitis in adults with acquired immunodeficiency syndrome (AIDS). Here's a breakdown of its key aspects:
What it treats:
- Cytomegalovirus (CMV) retinitis is a serious eye infection caused by the cytomegalovirus, which can potentially lead to vision loss in individuals with weakened immune systems, particularly those with AIDS.
- Brincidofovir is specifically indicated for treating CMV retinitis in adults with AIDS who are intolerant to or have failed treatment with other medications like ganciclovir (Cytovene) or foscarnet (Foscavir).
How it works:
- Brincidofovir belongs to a class of medications called nucleoside analogs. These medications work by mimicking the building blocks of viral DNA. When viruses try to incorporate brincidofovir into their DNA, it disrupts their replication and prevents them from multiplying.
How it's administered:
- Brincidofovir is typically given as an intravenous (IV) infusion over one to two hours, once every two weeks. The specific duration of treatment depends on various factors, including the patient's response and potential side effects.
Important considerations:
- Brincidofovir can cause various side effects, including nausea, vomiting, fever, fatigue, headache, and increased blood pressure.
- It can also decrease the levels of white blood cells, increasing the risk of infections. Regular monitoring of blood counts is crucial during treatment.
- Brincidofovir can cause birth defects if given during pregnancy. It is also not recommended for breastfeeding women.
- Due to the potential for serious side effects and complex administration, brincidofovir is typically used in hospital settings under the close supervision of a qualified healthcare professional.